New Zealand Clinical Research (NZCR) was formed in mid 2020 by the merger of Auckland Clinical Studies (ACS) and Christchurch Clinical Studies Trust (CCST). NZCR creates a stronger global player formed by bringing together two innovative and highly respected early phase clinical research units. NZCR is the result of over 34 years of combined research experience and brings expanded scale and capabilities. NZCR allows further development of the New Zealand clinical research infrastructure with the promise of delivering better treatment options for patients in New Zealand and around the world.